H. pylori Antibodies Rapid Test Device

Call For Pricing.

Model Number: NH-34521

Brand: Niche Healthcare

The H. pylori Antibody Rapid Test Device (Serum/Plasma) is a rapid chromatographic immunoassay for the qualitative detection of antibodies to H. pylori in serum or plasma to aid in the diagnosis of H. pylori infection.



Catalog No. HPAb-3012 Format Device
Specimen Serum/Plasm Certificate CE
Reading Time 10 minutes Test/Kit 40
Storage Temperature 4-30°C Shelf Life 2 Years
Sensitivity >99.9% Specificity >99.9%
Accuracy >99.9% Principle Chromatographic Interpretation


  1. Early Detection of Infection: The rapid test allows for the early detection of antibodies against H. pylori, aiding in the timely diagnosis of the infection.
  2. Treatment Planning: Identifying H. pylori infection is crucial for planning appropriate treatment strategies, which may include antibiotics and other medications. Early treatment can help prevent complications and improve patient outcomes.
  3. Reduction of Unnecessary Treatments: The test results can help healthcare providers avoid unnecessary treatments for patients without H. pylori infection, preventing the overuse of antibiotics and reducing the risk of antibiotic resistance.
  4. Monitoring Treatment Response: For patients undergoing treatment for H. pylori infection, the rapid test can be used to monitor the effectiveness of the treatment by assessing changes in antibody levels over time.
  5. Prevention of Complications: H. pylori infection is associated with various gastrointestinal conditions, including gastritis and peptic ulcers. Early detection and treatment can help prevent the progression of these conditions and reduce the risk of complications such as bleeding ulcers.
  6. Cost-Effective Diagnosis: Rapid tests are often cost-effective compared to more elaborate diagnostic methods, making them a valuable tool for healthcare systems aiming to optimize resource utilization.
  7. Public Health Surveillance: Monitoring the prevalence of H. pylori infections in the population through rapid testing can contribute to public health surveillance efforts. This information can be used for planning and implementing preventive measures.


Infectious Disease Trials

Infectious disease trials are conducted to address various aspects related to the prevention, treatment, and understanding of diseases caused by infectious agents, such as bacteria, viruses, parasites, or fungi. Here are some reasons for conducting infectious disease trials:

  1. Vaccine Development: Trials are crucial for testing the safety and efficacy of new vaccines aimed at preventing infectious diseases. This includes vaccines for viruses like influenza, human papillomavirus (HPV), and emerging threats like COVID-19.
  2. Antiviral and Antibiotic Testing: Clinical trials assess the effectiveness of new antiviral medications or antibiotics in treating infections. This is particularly important in addressing antibiotic resistance and finding alternative treatments.
  3. Understanding Disease Mechanisms: Trials help researchers understand the mechanisms of infectious diseases, including how pathogens spread, evade the immune system, and cause illness.
  4. Global Health Concerns: Trials play a vital role in addressing global health concerns, such as emerging infectious diseases (e.g., Ebola, Zika, COVID-19) and ongoing challenges like malaria, tuberculosis, and HIV.
  5. Public Health Interventions: Trials evaluate the effectiveness of public health interventions, such as strategies for disease prevention, control, and containment.
  6. Drug and Treatment Development: Researchers conduct trials to develop and test new drugs or treatment regimens for infectious diseases, aiming to improve outcomes for affected individuals.
  7. Surveillance and Epidemiology: Clinical trials contribute to surveillance efforts by providing data on disease prevalence, transmission patterns, and the effectiveness of control measures.

Infectious disease trials are essential for advancing our understanding of these diseases, developing effective interventions, and ultimately improving global public health. They contribute significantly to the development of evidence-based strategies for preventing, treating, and managing infectious diseases.


Types of Infections

Types of Infections


For more information, contact us 01274 965089 or check out our website at www.nicheofficesolutions.co.uk www.nicheofficesolutions.co.uk/niche-nhs

Further clinical information can be found on our blog page: www.nicheofficesolutions.co.uk/category/niche-healthcare-news

For products not found on our online website, please view our Healthcare catalogues: www.nicheofficesolutions.co.uk/healthcare-catalogues

View our Healthcare YouTube videos Playlist

If you have any additional questions, drop us an email at info@nicheofficesolutions.co.uk 


There are no reviews yet.

Be the first to review “H. pylori Antibodies Rapid Test Device”